This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2008 Feb 15;59(2):285-90.

doi: 10.1002/art.23345.

Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature

Nicolò Pipitone¹, Ignazio Olivieri, Angela Padula, Salvatore D'angelo, Angelo Nigro, Giulio Zuccoli, Luigi Boiardi, Carlo Salvarani

Affiliations

PMID: 18240181
DOI: 10.1002/art.23345

Review

Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature

Nicolò Pipitone et al. Arthritis Rheum. 2008.

. 2008 Feb 15;59(2):285-90.

doi: 10.1002/art.23345.

Authors

Nicolò Pipitone¹, Ignazio Olivieri, Angela Padula, Salvatore D'angelo, Angelo Nigro, Giulio Zuccoli, Luigi Boiardi, Carlo Salvarani

Affiliation

¹ Arcispedale Santa Maria Nuova, Reggio Emilia, Italy.

PMID: 18240181
DOI: 10.1002/art.23345

No abstract available

PubMed Disclaimer

Similar articles

Successful use of infliximab in a patient with neuro-Behçet's disease.
Abalos-Medina GM, Sánchez-Cano D, Ruiz-Villaverde G, Ruiz-Villaverde R, Quirosa Flores S, Raya Alvarez E. Abalos-Medina GM, et al. Int J Rheum Dis. 2009 Sep;12(3):264-6. doi: 10.1111/j.1756-185X.2009.01420.x. Int J Rheum Dis. 2009. PMID: 20374357
Effect of infliximab in progressive neuro-Behçet's syndrome.
Kikuchi H, Aramaki K, Hirohata S. Kikuchi H, et al. J Neurol Sci. 2008 Sep 15;272(1-2):99-105. doi: 10.1016/j.jns.2008.05.002. Epub 2008 Jun 11. J Neurol Sci. 2008. PMID: 18550081 Clinical Trial.
An attack of acute neuro-Behçet's disease during the course of chronic progressive neuro-Behçet's disease: report of two cases.
Matsui T, Ishida T, Tono T, Yoshida T, Sato S, Hirohata S. Matsui T, et al. Mod Rheumatol. 2010 Dec;20(6):621-6. doi: 10.1007/s10165-010-0332-4. Epub 2010 Jul 9. Mod Rheumatol. 2010. PMID: 20617356
Blind insight: eyeing anti-tumor necrosis factor treatment in uveitis associated with Behçet's disease.
Rosenbaum JT. Rosenbaum JT. J Rheumatol. 2004 Jul;31(7):1241-3. J Rheumatol. 2004. PMID: 15229938 Review. No abstract available.
Remission of Behçet's syndrome with TNFalpha blocking treatment.
Rozenbaum M, Rosner I, Portnoy E. Rozenbaum M, et al. Ann Rheum Dis. 2002 Mar;61(3):283-4. doi: 10.1136/ard.61.3.283-a. Ann Rheum Dis. 2002. PMID: 11830448 Free PMC article. Review. No abstract available.

See all similar articles

Cited by

Infliximab is a plausible alternative for neurologic complications of Behçet disease.
Zeydan B, Uygunoglu U, Saip S, Demirci ON, Seyahi E, Ugurlu S, Hamuryudan V, Siva A, Kantarci OH. Zeydan B, et al. Neurol Neuroimmunol Neuroinflamm. 2016 Jul 8;3(5):e258. doi: 10.1212/NXI.0000000000000258. eCollection 2016 Oct. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 27458602 Free PMC article.
Behçet's disease: recent advances in early diagnosis and effective treatment.
Calamia KT, Kaklamanis PG. Calamia KT, et al. Curr Rheumatol Rep. 2008 Oct;10(5):349-55. doi: 10.1007/s11926-008-0057-y. Curr Rheumatol Rep. 2008. PMID: 18817637 Review.
Effect of Infliximab on Chronic Progressive Neuro-Behçet's Disease: Influence of the Timing of Introduction on the Patient Outcome.
Hirohata S, Kikuchi H, Sawada T, Kuwana M, Kawachi I, Kirino Y, Ishigatsubo Y, Takeno M. Hirohata S, et al. Intern Med. 2024 Feb 15;63(4):481-486. doi: 10.2169/internalmedicine.1969-23. Epub 2023 Jun 21. Intern Med. 2024. PMID: 37344428 Free PMC article.
Behçet Disease: An Update for Dermatologists.
Alpsoy E, Bozca BC, Bilgic A. Alpsoy E, et al. Am J Clin Dermatol. 2021 Jul;22(4):477-502. doi: 10.1007/s40257-021-00609-4. Epub 2021 Jun 1. Am J Clin Dermatol. 2021. PMID: 34061323 Review.
Neuro-Behçet's disease in childhood: a focus on the neuro-ophthalmological features.
Mora P, Menozzi C, Orsoni JG, Rubino P, Ruffini L, Carta A. Mora P, et al. Orphanet J Rare Dis. 2013 Jan 29;8:18. doi: 10.1186/1750-1172-8-18. Orphanet J Rare Dis. 2013. PMID: 23360593 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information